Acute myeloid leukaemia (AML) 

We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia. Our services are based at University College Hospital and the University College Hospital Macmillan Cancer Centre and include outpatient and/or inpatient based chemotherapy, a full range of supportive care including complementary therapies, and stem cell transplantation where clinically appropriate.

We have close academic links with the University College London Cancer Institute and the majority of our consultants are involved in research programmes there. Many of our patients are offered the opportunity to get involved in national or locally run clinical trials providing access to the latest treatments.


Prof Adele Fielding, Consultant Haematologist

Prof Adele Fielding

Adele Fielding is Professor of Haematology at UCL with a clinical practice at UCLH, where she works within the leukaemia service. Her primary expertise is in acute lymphoblastic leukaemia. She chairs the UK National Cancer Research Institute Adult ALL subgroup. As a clinician scientist, she is heavily involved in the UK's clinical trials programme for ALL and am Chief Investigator of UKALL14 and UKALL60+, the UK's frontline academically-initiated trials for ALL. Her research lab program takes advantage of the opportunity to do translational work arising from these trials.

Full consultant profile

Dr Rajeev Gupta, Consultant Haematologist

Dr Rajeev Gupta

Dr Gupta is a consultant haematologist specialising in diagnostic haematology and treating patients with acute leukaemia admitted as inpatients. He is also a senior lecturer in haematology at the UCL Cancer Institute and his areas of research interest are haematopoietic stem cell biology and understanding cell state transitions in haematopoietic stem cells and how they impact cell fate decision making. 

“The most rewarding part of my work at UCLH providing a high quality 'state of the art' diagnostic facility for the haematological oncology service at UCLH is the most rewarding part of my work at UCLH”

Full consultant profile

Prof Asim Khwaja, Consultant Haematologist

Prof Asim Khwaja

Professor Asim Khwaja is a consultant haematologist at UCLH and professor of Haematology at the UCL Cancer Institute. He is lead clinician for adult acute leukaemias at UCLH specialising in the treatment of acute myeloid and lymphoid leukaemias. He is a member of the National Cancer Research Institute Haematological Oncology Clinical Studies Group and of the Cancer Research UK New Agents Committee. His area of particular research interest is studying the messages that cause blood cancer cells to grow out of control and in developing new targeted therapies that block these signals.

Full consultant profile

Dr Panagiotis Kottaridis, Consultant Haematologist

Dr Panagiotis Kottaridis

Dr Panos Kottaridis is a consultant haematologist specialising in leukaemia and bone marrow transplantation.

Dr Marc Mansour, Consultant Haematologist

Dr Marc Mansour

Dr Marc Mansour is an honorary consultant haematologist at UCLH and research group leader at the UCL Cancer Institute. He undertook his medical degree at the University of Edinburgh, medical training at King's College London and UCLH, followed by an MRC Clinical Research Training PhDship in the laboratory of Professors David Linch and Rosemary Gale at UCL, where he studied Notch signalling in acute leukaemia. He was funded by the Kay Kendell Leukemia Research Fund to undertake a travelling fellowship at Harvard Medical School and Dana-Farber Cancer Institute in Boston, USA. He was awarded the HMS Claudia Adams Barr Innovative Research award, and was a Harvard Medical School faculty member from 2012-2014. He is currently funded as a Bennett Senior Fellow by Bloodwise.

His research has focused on two aggressive haematological malignancies - T-cell acute lymphoblastic leukaemia (T-ALL) and acute myeloid leukaemia (AML). He has published extensively on the biology of acute leukaemia, authoring papers in Science, Nature, Nature Cell Biology, JCI, ELife, JCO and J Ex Med. His clinical interest is in ALL, AML and myelodysplasia (MDS).

Full consultant profile

Dr Beth Payne, Honorary Consultant Haematologist

Dr Beth Payne specialises in the treatment of MDS and Bone Marrow Failure. She is also a Senior Clinical Researcher funded by the Wellcome Trust and The Leuka John Goldman Fellowship for future Science and runs a research laboratory studying the mechanisms of disease in bone marrow failure and myelodysplastic syndromes and is also working to develop novel therapeutics.

Her areas of research interest are MDS and Bone Marrow Failure, especially Diamond-Blackfan Anaemia and 5q-syndrome MDS. She has also been involved in research projects in acute lymphoblastic leukaemia, acute myeloid leukaemias with CEBPA mutations and biology and management of familial MDS/leukaemia and bone marrow failure.

“The most rewarding part of my work is getting to know and treat patients and working with an amazing team of doctors, nurses and other support workers”

Full consultant profile

Dr Mallika Sekhar, Consultant Haematologist

Dr Mallika Sekhar

Dr Mallika Sekhar is a consultant haematologist and honorary senior lecturer at UCL specialising in myeloproliferative diseases across UCLH and Royal Free hospitals with a special interest in patients with vascular thrombosis and myeloproliferative diseases. Her other specialist areas include acute leukaemia and transfusion medicine. She has been involved in writing guidelines on MPD for BCSH.

Full consultant profile

 Clinical Nurse Specialists (CNS)

Clair Isworth, Myelodysplasia and Acute Leukaemia Clinical Nurse Specialist

Clair Isworth
Clair specialises in acute leukaemias, with a special interest in MyeloDysplastic syndromes (MDS) and aplastic anaemia (AA) and has spent her nursing career focusing on the care of cancer patients of all ages. She is currently undertaking her Masters degree and is researching innovation for excellence and service improvement, which is aimed at improving the patient experience through cancer treatment pathways.

“The most rewarding part of my role is to be able to implement change, and be part of leading a service and dedicated team that evolves and continues to strive for excellence for our patients and their outcomes”.

Gemma Trout, Leukaemia Clinical Nurse Specialist

Gemma Trout

Gemma specialises in adults with acute myeloid leukaemia, acute promyloctic leukaemia and acute lymphoblastic leukaemia. She also works with mylodysplasia and aplastic anaemia patients.

“The most rewarding part of working at UCLH is the incredible multi-disciplinary team that work in haematology to provide excellent, specialist care to our patients. I have worked in the Haematology Unit since qualifying in 1998 – how long I’ve been here is a testament to the team we have here. I am challenged every single day and I learn so much from my colleagues and my patients”